Innovation

Doppel offers its partners a significant added value through its dedicated R&D organization, staffed by over 20 highly qualified and specialized scientists and equipped with a broad range of advanced technologies enabling to provide high profile R&D activities

The applied research services include:

  • analytical development studies
  • formulation development
  • stability studies (ICH)
  • process development
  • scale-up
  • process validation
  • regulatory affairs
  • technology transfer
  • CTD documentation and product manufacturing and labelling for clinical trials.

The R&D Division also develops a range of highly innovative formulation technologies such as:

  • sustained and controlled release of oral solid dosage forms with various possible release profiles, including site specific delayed release delivery

Doppel

Established in 1994, Doppel is today recognized as one of Europe’s leading experts in contract R&D and manufacturing. It has start-of-the-art facilities and highest scientific capabilities to service its international pharmaceutical and nutritional clients.

The R&D Division also develops a range of highly innovative formulation technologies such as:

  • multi-layered tablets possessing combinations of release profiles of the same or different drugs in a single tablet
  • multi-particulate systems, such as granules or micro-tablets containing different dosages and release profiles, filled in a single capsule
  • bioavailability enhancement drug delivery systems for increasing permeability or solubility of active drugs
  • innovative delivery systems containing solids and liquids in one dosage form. delayed release delivery